Rigel Pharmaceuticals
RIGL
#6836
Rank
โ‚ฌ0.63 B
Marketcap
34,47ย โ‚ฌ
Share price
-0.91%
Change (1 day)
106.54%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ91.81 Million

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ91.81 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ0.10 B-32.68%
2024-12-31โ‚ฌ0.15 B17.02%
2023-12-31โ‚ฌ0.13 B-4.3%
2022-12-31โ‚ฌ0.13 B14.01%
2021-12-31โ‚ฌ0.12 B94.81%
2020-12-31โ‚ฌ62.07 M-25.83%
2019-12-31โ‚ฌ83.69 M227.53%
2018-12-31โ‚ฌ25.55 M66.04%
2017-12-31โ‚ฌ15.38 M-29.95%
2016-12-31โ‚ฌ21.96 M-40.5%
2015-12-31โ‚ฌ36.91 M73.43%
2014-12-31โ‚ฌ21.28 M65.09%
2013-12-31โ‚ฌ12.89 M-18.58%
2012-12-31โ‚ฌ15.83 M-1.87%
2011-12-31โ‚ฌ16.13 M4.38%
2010-12-31โ‚ฌ15.46 M-28.26%
2009-12-31โ‚ฌ21.55 M-24.1%
2008-12-31โ‚ฌ28.39 M23.36%
2007-12-31โ‚ฌ23.01 M16.76%
2006-12-31โ‚ฌ19.71 M-40.25%
2005-12-31โ‚ฌ32.99 M68.74%
2004-12-31โ‚ฌ19.55 M58.28%
2003-12-31โ‚ฌ12.35 M-31.69%
2002-12-31โ‚ฌ18.08 M-8.79%
2001-12-31โ‚ฌ19.82 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚ฌ73.04 B 79,465.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.42 B 63,533.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚ฌ69.19 M-24.63%๐Ÿ‡บ๐Ÿ‡ธ USA